{
    "xml": "<topic id=\"PHP5622\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/basiliximab\" basename=\"basiliximab\" title=\"BASILIXIMAB\">\n<title>BASILIXIMAB</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1338\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/monoclonal-antibodies/basiliximab\">Basiliximab</xref>\n</p>\n<data name=\"vtmid\">109135008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_402717286\" title=\"Monoclonal antibodies (anti-lymphocyte)\">Monoclonal antibodies (anti-lymphocyte)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP49530\" outputclass=\"drugAction\" rev=\"1.10\" parent=\"/drugs/basiliximab\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>\n<b>Basiliximab</b> is a monoclonal antibody that acts as an interleukin-2 receptor antagonist and prevents T-lymphocyte proliferation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49463\" outputclass=\"indicationsAndDose\" rev=\"1.39\" parent=\"/drugs/basiliximab\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of acute rejection in allogeneic renal transplantation used in combination with ciclosporin and corticosteroid-containing immunosuppression regimens (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 20&#8239;mg, administered within 2 hours before transplant surgery, followed by 20&#8239;mg after 4&#8239;days, dose to be administered after surgery, withhold second dose if severe hypersensitivity or graft loss occurs.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49625\" outputclass=\"cautions\" rev=\"1.12\" parent=\"/drugs/basiliximab\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Off-label use in cardiac transplantation&#8212;increased risk of serious cardiac side-effects</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49459\" outputclass=\"interactions\" rev=\"1.13\" parent=\"/drugs/basiliximab\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (basiliximab).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49418\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/basiliximab\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Atrial flutter</ph>; <ph outputclass=\"sideEffect\">cardiac arrest</ph>; <ph outputclass=\"sideEffect\">cytokine release syndrome</ph>; <ph outputclass=\"sideEffect\">palpitations</ph>; <ph outputclass=\"sideEffect\">severe hypersensitivity reactions</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49600\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/basiliximab\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Adequate contraception must be used during treatment and for 16 weeks after last dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49443\" outputclass=\"pregnancy\" parent=\"/drugs/basiliximab\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49650\" outputclass=\"breastFeeding\" parent=\"/drugs/basiliximab\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49693\" outputclass=\"directionsForAdministration\" rev=\"1.11\" parent=\"/drugs/basiliximab\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Simulect</i>\n<tm tmtype=\"reg\"/>) give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute 10&#8239;mg with 2.5&#8239;mL water for injections then dilute to at least 25&#8239;mL with infusion fluid; reconstitute 20&#8239;mg with 5&#8239;mL water for injections then dilute to at least 50&#8239;mL with infusion fluid; give over 20-30 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP5622-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/basiliximab\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75379\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/basiliximab/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78151\" namespace=\"/treatment-summaries/immune-response\" title=\"Immune response\" count=\"1\" rel=\"backlink\">Immune response</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1338\" namespace=\"/interactions/list-of-drug-interactions/cytotoxics/monoclonal-antibodies/basiliximab\" title=\"Basiliximab\" count=\"1\" rel=\"link\">Basiliximab</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75379\" namespace=\"/drugs/basiliximab/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP5622",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/basiliximab",
    "basename": "basiliximab",
    "title": "BASILIXIMAB",
    "interactants": [
        {
            "id": "bnf_int_1338",
            "label": "Basiliximab"
        }
    ],
    "vtmid": "109135008",
    "drugClassification": [
        "Monoclonal antibodies (anti-lymphocyte)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Basiliximab is a monoclonal antibody that acts as an interleukin-2 receptor antagonist and prevents T-lymphocyte proliferation.",
                "html": "<p>\n<b>Basiliximab</b> is a monoclonal antibody that acts as an interleukin-2 receptor antagonist and prevents T-lymphocyte proliferation.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of acute rejection in allogeneic renal transplantation used in combination with ciclosporin and corticosteroid-containing immunosuppression regimens (specialist use only)",
                        "html": "Prophylaxis of acute rejection in allogeneic renal transplantation used in combination with ciclosporin and corticosteroid-containing immunosuppression regimens (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intravenous injection or by intravenous infusion",
                    "html": "By intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 20 mg, administered within 2 hours before transplant surgery, followed by 20 mg after 4 days, dose to be administered after surgery, withhold second dose if severe hypersensitivity or graft loss occurs.",
                        "html": "<p>Initially 20&#8239;mg, administered within 2 hours before transplant surgery, followed by 20&#8239;mg after 4&#8239;days, dose to be administered after surgery, withhold second dose if severe hypersensitivity or graft loss occurs.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Off-label use in cardiac transplantation&#8212;increased risk of serious cardiac side-effects",
                "html": "Off-label use in cardiac transplantation&#8212;increased risk of serious cardiac side-effects"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (basiliximab).",
                "html": "<p>Appendix 1 (basiliximab).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Atrial flutter",
                        "html": "Atrial flutter",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cardiac arrest",
                        "html": "cardiac arrest",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cytokine release syndrome",
                        "html": "cytokine release syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "palpitations",
                        "html": "palpitations",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "severe hypersensitivity reactions",
                        "html": "severe hypersensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Adequate contraception must be used during treatment and for 16 weeks after last dose.",
                "html": "<p>Adequate contraception must be used during treatment and for 16 weeks after last dose.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Simulect ) give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute 10 mg with 2.5 mL water for injections then dilute to at least 25 mL with infusion fluid; reconstitute 20 mg with 5 mL water for injections then dilute to at least 50 mL with infusion fluid; give over 20-30 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Simulect</i>\n<tm tmtype=\"reg\"/>) give intermittently in Glucose 5% or Sodium chloride 0.9%; reconstitute 10&#8239;mg with 2.5&#8239;mL water for injections then dilute to at least 25&#8239;mL with infusion fluid; reconstitute 20&#8239;mg with 5&#8239;mL water for injections then dilute to at least 50&#8239;mL with infusion fluid; give over 20-30 minutes.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75379",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78151",
                "label": "Immune response",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1338",
                "label": "Basiliximab",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75379",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}